Epstein-Barr virus protein EB2 contains an N-terminal transferable nuclear export signal that promotes nucleocytoplasmic export by directly binding TAP/NXF1. Juillard F, Hiriart E, Sergeant N, Vingtdeux-Didier V, Drobecq H, Sergeant A, Manet E, Gruffat H. J Virol. 2009 Dec ;83(24):12759-68.
Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway. Ote I, Lebrun M, Vandevenne P, Bontems S, Medina-Palazon C, Manet E, Piette J, Sadzot-Delvaux C. PLoS One. 2009 Nov 18 ;4(11):e7882.
HSV-1-derived amplicon vectors : recent technological improvements and remaining difficulties—a review. Epstein AL. Mem Inst Oswaldo Cruz. 2009 May ;104(3):399-410. Review.
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1. Apcher S, Komarova A, Daskalogianni C, Yin Y, Malbert-Colas L, Fåhraeus R. J Virol. 2009 Feb ;83(3):1289-98.
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. Tsitoura E, Thomas J, Cuchet D, Thoinet K, Mavromara P, Epstein AL. J Gen Virol. 2009 Sep ;90(Pt 9):2209-20. Epub 2009 Jun 10.
Progress and prospects : biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors. Epstein AL. Gene Ther. 2009 Jun ;16(6):709-15. Epub 2009 Apr 16. Review.
Macroautophagy signaling and regulation. Esclatine A, Chaumorcel M, Codogno P. Curr Top Microbiol Immunol. 2009 ;335:33-70. Review.
Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. Alazard-Dany N, Nicolas A, Ploquin A, Strasser R, Greco A, Epstein AL, Fraefel C, Salvetti A. PLoS Pathog. 2009 Mar ;5(3):e1000340. Epub 2009 Mar 13.
Testing the susceptibility of human herpesviruses to antivirals.Agut H, Boutolleau D, Deback C, Bonnafous P, Gautheret-Dejean A.Future Microbiol. 2009 Nov ;4(9):1111-23. Review.
The flexible motif V of Epstein-Barr virus deoxyuridine 5’-triphosphate pyrophosphatase is essential for catalysis.Freeman L, Buisson M, Tarbouriech N, Van der Heyden A, Labbé P, Burmeister WP. J Biol Chem. 2009 Sep 11 ;284(37):25280-9.
Varicella vaccination in Europe - taking the practical approach. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, Weil-Olivier C, Wutzler P. BMC Med. 2009 May 28 ;7:26. Review.
Expression of Epstein-Barr virus EBNA1 protein in Escherichia coli : purification under nondenaturing conditions and use in DNA-binding studies. Bouallag N, Gaillard C, Maréchal V, Strauss F. Protein Expr Purif. 2009 Sep ;67(1):35-40.
Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Dellis O, Arbabian A, Brouland JP, Kovàcs T, Rowe M, Chomienne C, Joab I, Papp B. Mol Cancer. 2009 Aug 3 ;8:59.
Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor. Boutolleau D, Deback C, Bressollette-Bodin C, Conan F, Aït-Arkoub Z, Imbert-Marcille BM, Agut H. Antivir Ther. 2009 ;14(6):847-52.
Different expression of human herpesvirus-6 (HHV-6) load in whole blood may have a significant impact on the diagnosis of active infection. Gautheret-Dejean A, Henquell C, Mousnier F, Boutolleau D, Bonnafous P, Dhédin N, Settegrana C, Agut H. J Clin Virol. 2009 Sep ;46(1):33-6. Epub 2009 Jun 7.
Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections : Evaluation on whole blood specimens and proficiency panels. Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H, Boutolleau D. J Virol Methods. 2009 Aug ;159(2):291-4.
Length variability of telomeric repeat sequences of human herpesvirus 6 DNA. Achour A, Malet I, Deback C, Bonnafous P, Boutolleau D, Gautheret-Dejean A, Agut H. J Virol Methods. 2009 Jul ;159(1):127-30.
Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction : contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation.Oussaief L, Hippocrate A, Ramirez V, Rampanou A, Zhang W, Meyers D, Cole P, Khelifa R, Joab I. J Biol Chem. 2009 Sep 4 ;284(36):23912-24. Epub 2009 Jul 9.
Activation of the lytic program of the Epstein-Barr virus in Burkitt’s lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent. Oussaief L, Hippocrate A, Clybouw C, Rampanou A, Ramirez V, Desgranges C, Vazquez A, Khelifa R, Joab I. Virology. 2009 Apr 25 ;387(1):41-9.
Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation. Jeulin H, Salmon A, Gautheret-Dejean A, Agut H, Bordigoni P, Fortier B, Venard V. J Clin Virol. 2009 May ;45(1):43-6. Epub 2009 Mar 24.
Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains. Deback C, Boutolleau D, Depienne C, Luyt CE, Bonnafous P, Gautheret-Dejean A, Garrigue I, Agut H. J Clin Microbiol. 2009 Mar ;47(3):533-40.
Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection. Boutolleau D, Deback C, Bressollette-Bodin C, Varnous S, Dhedin N, Barrou B, Vernant JP, Gandjbakhch I, Imbert-Marcille BM, Agut H. Antiviral Res. 2009 Feb ;81(2):174-9.
The Marek’s disease virus (MDV) protein encoded by the UL17 ortholog is essential for virus growth. Chbab N, Chabanne-Vautherot D, Francineau A, Osterrieder O, Denesvre C, Vautherot JF. Veterinary Research, 2009 ; 40 : 28.
Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene. Larrat S, Morand P, Bas A, Vigne S, Crance JM, Boyer V, Nicod S, Grossi L, Buisson M, Burmeister WP, Seigneurin JM, Germi R. Antivir Ther. 2009 ;14(5):655-62.
A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. Buisson M, Géoui T, Flot D, Tarbouriech N, Ressing ME, Wiertz EJ, Burmeister WP. J Mol Biol. 2009 Aug 28 ;391(4):717-28.
Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Draskovic I, Arnoult N, Steiner V, Bacchetti S, Lomonte P, Londoño-Vallejo A. Proc Natl Acad Sci U S A. 2009 Sep 15 ;106(37):15726-31
Translation of intronless RNAs is strongly stimulated by the Epstein-Barr virus mRNA export factor EB2. Ricci EP, Mure F, Gruffat H, Decimo D, Medina-Palazon C, Ohlmann T, Manet E. Nucleic Acids Res. 2009 Aug ;37(15):4932-43.
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Klibi J, Niki T, Riedel A, Pioche-Durieu C, Souquere S, Rubinstein E, Le Moulec S, Guigay J, Hirashima M, Guemira F, Adhikary D, Mautner J, Busson P. Blood. 2009 Feb 26 ;113(9):1957-66.
Strong correlations of anti-Viral Capsid Antigen antibody levels in first-degree relatives from families with Epstein Barr Virus-related lymphomas. Besson C, Amiel C, Le-Pendeven C, Plancoulaine S, Bonnardel C, Ranque B, Abbed K, Brice P, Fermé C, Carde P, Hermine O, Raphael M, Bresson JL, Nicolas JC, Gessain A, deThe G, Abel L. J Infect Dis 2009 ;199:1121-7.
c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J. J Virol. 2009 May ;83(10):5014-27.
Interaction of Epstein-Barr virus BZLF1 C-terminal tail structure and core zipper is required for DNA replication but not for promoter transactivation.McDonald CM, Petosa C, Farrell PJ. J Virol. 2009 Apr ;83(7):3397-401.
The genetic diversity of three peculiar populations descending from the slave trade : Gm study of Noir Marron from French Guiana. Brucato N, Tortevoye P, Plancoulaine S, Guitard E, Sanchez-Mazas A, Larrouy G, Gessain A, Dugoujon JM. C R Biol. 2009 Oct ;332(10):917-26.
EBV-associated mononucleosis does not induce long-term global deficit in T-cell responsiveness to IL-15. Giron-Michel J, Ménard F, Negrini S, Devocelle A, Azzarone B, BessonC. Blood 2009 ;113:4541-7.
Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC. PLoS Pathog. 2009 Mar ;5(3):e1000356.
Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos). Aho S, Lupo J, Coly PA, Sabine A, Castellazzi M, Morand P, Sergeant A, Manet E, Boyer V, Gruffat H. Biol Cell. 2009 Jun ;101(6):319-34.